ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.20
-0.26 (-4.76%)
At close: May 26, 2026, 4:00 PM EDT
5.12
-0.08 (-1.54%)
After-hours: May 26, 2026, 7:58 PM EDT
ENDRA Life Sciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
6.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inotiv | 507.36M |
| MDxHealth | 110.97M |
| FONAR | 105.34M |
| Exagen | 68.38M |
| XWELL | 28.83M |
| Precipio | 25.83M |
| bioAffinity Technologies | 5.66M |
| iSpecimen | 1.03M |
NDRA News
- 8 days ago - Endra Life Sciences reports Q1 EPS ($1.09) vs. ($1.86) last year - TheFly
- 8 days ago - ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 11 days ago - ENDRA Life Sciences Quarterly report: Q1 2026 - Filings
- 12 days ago - Endra Life Sciences reports multi-site validation of TAEUS Liver device - TheFly
- 12 days ago - ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility - Business Wire
- 13 days ago - ENDRA Life Sciences Inc trading halted, volatility trading pause - TheFly
- 13 days ago - ENDRA Life Sciences Inc trading resumes - TheFly
- 2 months ago - Endra Life Sciences reports Q4 EPS ($8.93) vs ($56.94) last year - TheFly